Structured evidence table for Policosanol Cholesterol Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Policosanol Cholesterol Meta-Analysis | Conclusion Policosanol supplementation has no significant effect on creatinine levels. | 1 | Amini MR (2025) | The effects of policosanol supplementation on creatinine: a systematic review and dose-response meta-analysis of randomized controlled trials. |
| Policosanol Cholesterol Meta-Analysis | Objective Policosanol, a compound generated from sugar cane, consists of alcohols such as octacosanol, hexacosanol, and triacontanol, which possess antioxidant properties. | 1 | Amini MR (2025) | The effects of policosanol supplementation on creatinine: a systematic review and dose-response meta-analysis of randomized controlled trials. |
| Policosanol Cholesterol Meta-Analysis | Evaluating the impact of this antioxidant on serum creatinine in clinical settings is essential because of the contradictory findings. | 1 | Amini MR (2025) | The effects of policosanol supplementation on creatinine: a systematic review and dose-response meta-analysis of randomized controlled trials. |
| Policosanol Cholesterol Meta-Analysis | It is concluded that oral administration of policosanol 20 mg/day for twelve weeks significantly lowered SBP and DBP in Cuban patients with grade I hypertension, and improved lipid profile variables, being safe and well tolerated. | 2 | Revueltas Aguero M (2025) | Policosanol (sugarcane wax alcohols) 20 mg/day in Cuban Patients With Grade I Hypertension: A Randomized, Double-Blind, Multicenter Study. |
| Policosanol Cholesterol Meta-Analysis | This study aimed to report the effects of policosanol (20 mg/day) on blood pressure values in Cuban patients with grade I hypertension. | 2 | Revueltas Aguero M (2025) | Policosanol (sugarcane wax alcohols) 20 mg/day in Cuban Patients With Grade I Hypertension: A Randomized, Double-Blind, Multicenter Study. |
| Policosanol Cholesterol Meta-Analysis | A double-blind multicenter trial randomized 400 eligible patients divided into two strata of patients with either prehypertension or grade I hypertension (200 patients each) treated with either placebo or policosanol 20 mg/day (100 patients/group/stratum) for 12 weeks. | 2 | Revueltas Aguero M (2025) | Policosanol (sugarcane wax alcohols) 20 mg/day in Cuban Patients With Grade I Hypertension: A Randomized, Double-Blind, Multicenter Study. |
Source documents